NOV 17, 2016 01:03 PM PST

Antiphospholipid Syndrome may be Triggered by gut Bacteria

WRITTEN BY: Carmen Leitch
Researchers studying antiphospholipid syndrome (APS) found that patients with the disease have high levels of bacteria that make phospholipids.  It has been previously established that antiphospholipid antibodies have pathogenic roles, so the scientists decided to assay fecal samples of patients with the disease to look for a source of the perpetual stimulation of those antibodies. Their findings indicate that microbes are a likely cause of APS, a life-threatening condition. To know more about APS, watch the following video.
 


APS is an autoimmune disease that primarily affects young women. There are antiphospholipid antibodies in those suffering from deep vein thrombosis, as well as in those who have experienced a stroke while under the age of 50. The antibodies are also a cause of complications during pregnancy and recurrent miscarriages.

"Transient antiphospholipid antibodies have long been associated with infections, but are not considered disease-related," said Martin A. Kriegel, MD, PhD, Assistant Professor of Immunology and Medicine and the study's lead author. "We hypothesized that commensals (microbes that normally reside in the gut) that chronically colonize us, instead of acute infections that resolve over time, might be the persistent triggers of APS in patients."

The cause of APS is not yet known, and blood thinners are the only treatment option, used to target the blood clots that appear in the final stage of disease, explained Kriegel. In this work, presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, the researchers wanted to investigate early triggers of the disease in an effort to prevent strokes and miscarriages.

"There's still significant mortality associated with this syndrome compared to other rheumatic diseases in which we can largely prevent mortality nowadays. So there is a huge need to better understand and treat this syndrome," Kriegel said.

For this study, the following were collected: 60 stool samples of 22 APS patients, 13 samples of six control subjects with thrombophilic (likely to form blood clots) and non-autoimmune states. For comparison, 49 samples of 19 healthy donors, each at baseline, at four and eight weeks, were sampled.

Peripheral blood mononuclear cells (PBMCs) from the APS patients responded preferentially to β2-glycoprotein I (GPI), a major auto-antigen in APS, compared to the controls. An assay of the fecal microbiomes of APS patients indicated an increase in Slackia bacteria, which can make phospholipids, and a decrease in Bilophilia bacteria. Those altered bacteria levels correlated with the production of antibodies.

"The study's findings are early, but suggest that certain gut microbes are enriched across time in APS patients compared to control subjects. Since we performed not only a cross-sectional microbiome study, but sampled our patients at thee monthly time points and tested how much microbes are coated with IgA antibodies from the patients, we believe that the gut microbes we identified as promising candidates should be studied further," said Kriegel. "These eventually may become biomarkers of disease or even treatment targets, but we're still far away from these goals."

"The immediate next step is to culture the candidate bacteria that emerged from the study and put them together with immune cells from the patients," he said. "In particular, we would like to test if cardiolipin could be derived from our candidate bacteria and, therefore, be recognized by the patients' immune cells that are known to target these lipids," concluded Kriegel.

Read more about APS here.

Sources: Lupus, AAAS/Eurekalert! via American College of Rheumatology
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 08, 2018
Microbiology
JUL 08, 2018
Natural Molecule has a Potent Anti-inflammatory Impact
A compound that is naturally made by a bacterium called Francisella tularensis can impair the immune response....
JUL 24, 2018
Microbiology
JUL 24, 2018
Salmonella Outbreak Linked to Raw Turkey Products
Researchers at the CDC are trying to learn more about a rash of Salmonella infections....
SEP 15, 2018
Microbiology
SEP 15, 2018
Researchers Surprised to Find Bacteria That Make Electricity in the Human Gut
It seems that many microbes, including strains in the human gut that are potentially pathogenic, can generate electricity....
SEP 20, 2018
Videos
SEP 20, 2018
The Lowdown on Vaccine Development and Production
Learn more about how vaccines are developed and tested, from the CDC....
SEP 22, 2018
Videos
SEP 22, 2018
Did a Vampire Facial Expose Patients to Bloodborne Disease?
It seems there is no shortage of unusual beauty rituals; vampire facials may fall into that category....
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
Loading Comments...